Tuesday November 24 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

BioPortfolio's Approved Drugs Database

Remodulin

Treprostinil Sodium

Download PDF containing detailed information.PDF Version

Image Results

Loading...

Press Releases About Remodulin:

 BioPortfolio Logo
United Therapeutics Corporation Reports Third Quarter 2009 Financial Results 29th October, 2009 United Therapeutics Corporation
SILVER SPRING, Md., Oct. 29 /PRNewswire-FirstCall/ -- United Therapeutics Corporation (Nasdaq: UTHR) today announced its results of operations for the quarter ended September 30, 2009. Revenues for
United Therapeutics Reports First Quarter 2009 Financial Results 1st May, 2009 United Therapeutics Corporation
- Revenues of $79.7 Million, Increase of 29% over First Quarter 2008 - Earnings Per Share of $0.50 per Basic Share and $0.49 per Diluted Share, Increases of 14% and 20% over First Quarter 2008,
Lilly Licenses U.S. Rights for Tadalafil PAH Indication to United Therapeutics 17th November, 2008 Eli Lilly and Company
INDIANAPOLIS and SILVER SPRING, Md., Nov. 17 /PRNewswire-FirstCall/ -- Eli Lilly and Company (NYSE: LLY) and United Therapeutics Corporation (Nasdaq: UTHR) today announced that the two companies
United Therapeutics Reports Third Quarter 2008 Financial Results 30th October, 2008 United Therapeutics Corporation
SILVER SPRING, Md., Oct. 30 /PRNewswire-FirstCall/ -- United Therapeutics Corporation (Nasdaq: UTHR) today announced its results of operations for the quarter ended September 30, 2008. Total
United Therapeutics Reports Second Quarter 2008 Financial Results 31st July, 2008 United Therapeutics Corporation
SILVER SPRING, Md., July 31 /PRNewswire-FirstCall/ -- United Therapeutics Corporation (Nasdaq: UTHR) today announced its results of operations for the quarter ended June 30, 2008. Total

This page has been viewed 27 times Browse BioPortfolio's InDepth service - alphabetically: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z or by Most Publications, recently searched for, or most viewed.

Search for Remodulin across BioPortfolio, or for Remodulin Research Reports
Wikipedia excerpt, where present, licenced under the GNU Free Documentation License. Resources from the NCBI applied. Selected MeSH subject headings created and maintained by the US NLM are used in conjunction with additional keywords. 2006-2008 MeSH. Thumbshots from Thumbshots.org

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.